Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
暂无分享,去创建一个
Michael P Sigalas | Dimitrios Bikiaris | Evangelos Karavas | D. Bikiaris | K. Avgoustakis | E. Karavas | Konstantinos Avgoustakis | Emmanuel Georgarakis | M. Sigalas | E. Georgarakis
[1] Jeong-Sook Park,et al. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. , 2005, International journal of pharmaceutics.
[2] L. Gargallo,et al. Unperturbed dimensions of polyvinylpyrrolidone in pure solvents and in binary mixtures , 1977 .
[3] O. Corrigan. Mechanisms of Dissolution of Fast Release Solid Dispersions , 1985 .
[4] C. Nyström,et al. Physicochemical aspects of drug release: X. Investigation of the applicability of the cube root law for characterization of the dissolution rate of fine particulate materials , 1990 .
[5] L. Adamowicz,et al. IR spectral and theoretical characterization of intramolecular hydrogen bonds closing five-membered rings , 2001 .
[6] E. Pavlidou,et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques , 2005 .
[8] Jm Newton,et al. THE DISSOLUTION OF NORTRIPTYLINE HCL FROM POLYETHYLENE-GLYCOL SOLID DISPERSIONS , 1992 .
[9] S. Riegelman,et al. Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.
[10] W. Stockmayer. Problems of the statistical thermodynamics of dilute polymer solutions , 1960 .
[11] A. Serajuddin,et al. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.
[12] N. Peppas,et al. Drug/Polymer Matrix Swelling and Dissolution , 2004, Pharmaceutical Research.
[13] I. Pajeva,et al. Interactions of Poly(vinylpyrrolidone) with Ibuprofen and Naproxen: Experimental and Modeling Studies , 2005, Pharmaceutical Research.
[14] Dimitrios N. Bikiaris,et al. Hydrophilic matrices as carriers in felodipine solid dispersion systems , 2001 .
[15] D. L. Munday,et al. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] Ž. Knez,et al. Micronization of drugs using supercritical carbon dioxide. , 1999, International journal of pharmaceutics.
[17] D. Craig,et al. An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersions , 1992 .
[18] Evangelos Karavas,et al. Miscibility Behavior and Formation Mechanism of Stabilized Felodipine-Polyvinylpyrrolidone Amorphous Solid Dispersions , 2005, Drug development and industrial pharmacy.
[19] Aditya Mohan Kaushal,et al. Amorphous drug delivery systems: molecular aspects, design, and performance. , 2004, Critical reviews in therapeutic drug carrier systems.
[20] A. Xenakis,et al. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] J. Newton,et al. Assessment of the wettability of powders by use of compressed powder discs , 1986 .
[22] W. L. Chiou,et al. PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSIONS , 1971 .
[23] Y. Marcus,et al. An empirical correlation between stretching vibration redshift and hydrogen bond length , 2000 .
[24] J. Dressman,et al. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.
[25] R. Bodmeier,et al. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[26] S. Clas,et al. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. , 2000, Journal of pharmaceutical sciences.
[27] J. B. Park,et al. Characteristics of felodipine-located poly(ε-caprolactone) microspheres , 2005 .
[28] D. Craig,et al. The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.
[29] A. Bansal,et al. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. , 2005, Molecular pharmaceutics.
[30] C. Nyström,et al. Physicochemical aspects of drug release. VI. Drug dissolution rate from solid particulate dispersions and the importance of carrier and drug particle properties , 1988 .
[31] D. Bikiaris,et al. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[32] A. Bansal,et al. Devitrification of amorphous celecoxib , 2005, AAPS PharmSciTech.
[33] B. Abrahamsson,et al. Evaluation of Solubilizers in the Drug Release Testing of Hydrophilic Matrix Extended-Release Tablets of Felodipine , 1994, Pharmaceutical Research.
[34] D. Bikiaris,et al. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. , 2006, International journal of pharmaceutics.